PME-1 is a protein that modifies other proteins by removing methyl groups, but high levels of PME-1 are observed in some diseases, including Alzheimer’s disease (AD) and cancer. In a recent study published in The FASEB Journal,…
Targeting PME-1 may offer new strategies for treating neurological disorders and cancer
